The following represents disclosure information provided by authors of this abstract. The program committee has reviewed all presenting author disclosure reports, identified potential conflicts of interest, and implemented strategies to manage those areas of conflict, where appropriate. All relationships are considered compensated. Relationships are self-held unless otherwise noted. I = Immediate Family Member, Inst = My Institution
 
Open Payments is a public database containing information reported by companies about payments made to US-licensed physicians (Open Payments)
 
 
Honoraria - Chugai Pharma; Novartis
Exploring predictive factors for detecting KRAS mutations in pancreatic cancer using liquid biopsy.
 
Takaaki Furukawa
No Relationships to Disclose
 
Ippei Fukada
Honoraria - Bayer; Chugai Pharma; Eisai; Guardant Health
 
Naomi Hayashi
No Relationships to Disclose
 
Manabu Takamatsu
Honoraria - Daiichi Sankyo; EA Pharma
Consulting or Advisory Role - Astellas Pharma
 
Yoichiro Sato
No Relationships to Disclose
 
Yuri Maegawa
No Relationships to Disclose
 
Tatsuki Hirai
No Relationships to Disclose
 
Takafumi Mie
Honoraria - Boston Scientific; J-MIT; Japan Lifeline; SERVIER
 
Takeshi Okamoto
Honoraria - AstraZeneca Japan; Chugai Pharma; Eisai
 
Tsuyoshi Takeda
Honoraria - Boston Scientific; Ono Pharmaceutical; SB Kawasumi; Taiho Pharmaceutical
 
Takashi Sasaki
Honoraria - AstraZeneca Japan; Eisai; MSD; Taiho Pharmaceutical
 
Masato Ozaka
Honoraria - AstraZeneca; Bayer; Eisai; MSD; Novartis; Ono Pharmaceutical; Pfizer; SERVIER; Taiho Pharmaceutical; Takeda; Yakult Honsha
 
Shunji Takahashi
Honoraria - Bayer; Bristol-Myers Squibb Japan; Chugai Pharma; Daiichi Sankyo; Eisai; Lilly Japan; MSD; Ono Pharmaceutical; Taiho Pharmaceutical
Consulting or Advisory Role - Bayer
Research Funding - Amgen (Inst); Astellas Pharma (Inst); AstraZeneca (Inst); Bayer (Inst); Boehringer Ingelheim (Inst); Bristol-Myers Squibb (Inst); Chugai Pharma (Inst); Daiichi Sankyo (Inst); Eisai (Inst); Lilly (Inst); MSD (Inst); Novartis (Inst); Ono Pharmaceutical (Inst); Pfizer/EMD Serono (Inst); Sanofi (Inst); Seagen (Inst); Taiho Pharmaceutical (Inst)
 
Naoki Sasahira
No Relationships to Disclose